Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Markov chain model of a longitudinal breast cancer data set
    Meeting Abstract

    Newton, P. K.; Nieva, J. J.; Kuhn, P.; Norton, L.; Comen, E. A.; Mason, J.; Venkatappa, N.; Jochelson, M. S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103
    Meeting Abstract

    Miller, K.; O'Neill, A. M.; Dang, C. T.; Northfelt, D. W.; Gradishar, W. J.; Goldstein, L. J.; Mayer, I. A.; Brufsky, A.; Bloom, S. H.; Sparano, J. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Adjuvant palbociclib (P) plus endocrine therapy (ET) for hormone receptor positive (HR plus ) breast cancer: A phase II feasibility study
    Meeting Abstract

    Mayer, E. L.; Gropper, A. B.; Tung, N. M.; Higgins, M. J.; Traina, T. A.; Barry, W. T.; Winer, E. P.; Burstein, H. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2-proficient triple-negative breast cancer (TNBC)-Evaluating the homologous recombination deficiency (HRD) biomarker
    Meeting Abstract

    Mayer, E. L.; Vaz-Luis, I.; Richardson, A. L.; Perou, C. M.; Tung, N. M.; Abramson, V. G.; Anders, C. K.; Forero-Torres, A.; Marcom, P. K.; Miller, K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Obesity and menopausal status as determinants of procarcinogenic breast inflammation
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Zhou, X. K.; Gucalp, A.; Giri, D. D.; Harbus, M.; Falcone, D. J.; Vandat, L. T.; Awad, M. I.; Krasne, M. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of PARP inhibition as a platinum sparing strategy in BRCA2-deficient pancreatic tumors
    Meeting Abstract

    Lowery, M. A.; Lee, A.; Tobias, E.; Sung, P.; Bhanot, U.; Shakya, R.; Ludwig, T.; O'Reilly, E. M.; Jasin, M.; Moynahan, M. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009
    Meeting Abstract

    Isakoff, S. J.; He, L.; Mayer, E. L.; Goss, P. E.; Traina, T. A.; Carey, L. A.; Krag, K.; Liu, M. C.; Rugo, H. S.; Stearns, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save